Catheter Precision Inc VTAK

Healthcare Medical Devices

Catheter Precision, Inc. is a medical device company. It is engaged in providing new solutions to the market to improve the treatment of cardiac arrhythmias. It is focused on developing technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. It is also focused on developing and delivering electrophysiology products to provide patients, hospitals, and physicians with novel technologies and solutions to improve the lives of patients with cardiac arrhythmias. Its product is the VIVO System, which is an anacronym for View into Ventricular Onset System, which is a non-invasive imaging system that offers three-dimensional cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients. Its LockeT product is a suture retention device indicated for wound healing. Its product portfolio also includes the Amigo Remote Catheter System, a robotic arm that serves as a catheter control device.

NYSEAM:VTAK - Post by User

Catheter Precision Inc

<< Previous

Bullboard Posts

Next >>

Post by averagepennieson Oct 10, 2023 8:42am

46 Views

Post# 35676681

Catheter Precision Showcasing its Innovative 3D Mapping

VIVO to Be Highlighted at Several Electrophysiology Conferences

FORT MILL, SC / ACCESSWIRE / October 10, 2023 / Catheter Precision, Inc. (the "Company") (NYSE American:VTAK) announced that its innovative 3D Mapping system will be highlighted at several electrophysiology conferences this fall.

Most recently, VIVO was highlighted at the 19th Congresso Nazionale Associazione Italiana di Aritmologia e Cardiostimolazione in Bologna, Italy from September 21-22. Interim CEO David Jenkins remarked, "Our attendance not only highlighted our state-of-the-art technology but also cemented collaborations for evaluations at prominent VIVO sites, including Ospedale Della Misericordia Grosseto and Pisa CNR. VIVO received commendable feedback, recognizing its potential to revolutionize patient experience and EP lab efficiency."

Strengthening their foothold in Italy, Catheter Precision has strategically partnered with Precise S.r.l. "Our alliance with Precise S.r.l. is instrumental in solidifying our presence in the Italian medical landscape," Jenkins concluded.

In addition to VIVO, Catheter Precision will be present at other conferences also highlighting their newly introduced product, LockeT, a venous stasis closure device.

Future conferences that will highlight VIVO in the coming weeks are listed below.

Irish Cardiac Society's 74th Annual Scietific Meeting, October 12-14, 2023:
- Presentation: "Testing the Validity of VIVO Technology: A Deep Dive into Ventricular Onset Mapping" by Professor Szeplaki's team from Mater Private Hospital, Dublin.
18th Annual International Symposium on Ventricular Arrythmias, October 13-14, 2023
- Location: Philadelphia, Pennsylvania
- Spotlight: VIVO and LockeT products
7th Annual Society of Cardiac RN Meeting, October 19-20, 2023:
- Location: Washington, DC
- Presentation: "3D Mapping for Robotic Ventricular Ablations Using VIVO" by Dr. Benjamin D'Souza from Penn Presbyterian Medical Center, Philadelphia, PA.